AI in Clinical Development: Insights on adoption, value and future impact

AI is everywhere in clinical development. Its impact is still hard to define.

New data from ISR Market Research, part of the ramarketing group, reveals how pharma teams are actually using AI today, where it’s delivering value, and why many organizations are struggling to turn adoption into meaningful impact.

Download the report

Based on insights from 125 pharma and biotech professionals across the US and Europe, this report provides a grounded view of AI in clinical development today.

Inside, you’ll uncover:

• Where AI is already delivering value
• How organizations are managing trust and risk
• The gap between AI capability and real-world application
• The areas where teams expect AI to drive the most impact next

From insight to impact

ISR Market Research brings deep, data-led visibility into how the industry is evolving through this report; ramarketing brings the commercial context to act on it.

Together, that means moving beyond understanding AI adoption, to answering a more critical question: How do you turn AI from a productivity tool into a driver of competitive advantage?

If AI is already part of your workflows, this download will help you understand what comes next.